Role of human cytochrome P‐450s in risk assessment and susceptibility to environmentally based disease

References

• Buchert , E. and Woosley , R. L. 1992 . Clinical implications of variable antiarrythinic drug metabolism . Pharmacogenetics , 2 : 2 – 11 .
   PubMedGoogle Scholar
• Butler , M. A. , Iwasaki , M. , Guengerich , F. P. and Kadlubar , F. F. 1989 . Human cytochrome P450 (P4501A2), the phenacetin O‐deethylase, is primarily responsible for the hepatic 3‐demethylation of caffeine and the N‐oxidation of carcinogenic arylamines . Proc. Natl. Acad. Sci. USA , 86 : 7696 – 7700 .
   PubMed Web of Science ®Google Scholar
• Butler , M. A. , Lang , N. P. , Young , J. F. , Caporaso , W. E. , Vineis , P. , Hayes , R. B. , Teitel , C. H. , Massengill , J. P. , Lawsen , M. F. and Kadlubar , F. F. 1992 . Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites . Pharmacogenetics , 2 : 116 – 127 .
   PubMedGoogle Scholar
• Caporaso , N. , Landi , M. T. and Vinies , P. 1991 . Relevance of metabolic polymorphisms to human car‐cinogenesis: evaluation of epidemiologic evidence . Pharmacogenetics , 1 : 4 – 19 .
   PubMedGoogle Scholar
• Cholerton , S. , Idle , M. E. , Vas , A. , Gonzalez , F. J. and Idle , J. R. 1992 . Comparison of a novel thin‐layer chromotography fluorescence detection method with a spectrofluoromatric method for determination of 7‐hydroxycoumarin in human urine . J. Chromatogr. , 570 : 325 – 330 .
   Google Scholar
• Cohen , M. B. , Schuler , M. A. and Berenbaum , M. R. 1992 . A host‐inducible P450 from a host‐specific caterpillar: Molecular cloning and evolution . Proc. Natl. Acad. Sci. USA , 89 : 10920 – 10924 .
   PubMed Web of Science ®Google Scholar
• Crespi , C. L. 1991 . Expression of cytochrome P450 cDNA in human B‐lymphoblastoid cells: Applications to toxicology and metabolite analysis . Methods Enzmol. , 206 : 123 – 130 .
   PubMed Web of Science ®Google Scholar
• Crespi , C. L. and Thilly , W. G. 1984 . Assay for gene mutation in a human lymphoblast line, AHH‐1, competent for xenobiotic metabolism . Mutat. Res. , 128 : 221 – 230 .
   PubMedGoogle Scholar
• Crespi , C. L. , Penman , B. W. , Leakey , J. A. E. , Arlotto , M. , Stark , A. , Turner , T. , Steimel , B. T. , Rudo , K. , Davies , R. L. and Langenbach , R. 1990 . Human cytochrome P450IIA3: cDNA sequence role of the enzyme in the metabolic activation of promutagens: Comparison to nitrosamine activation by human cytochrome P450IIE1 . Carcinogenesis , 11 : 1293 – 1300 .
   PubMed Web of Science ®Google Scholar
• Crespi , C. L. , Gonzalez , F. J. , Steimel , D. T. , Turner , T. R. , Gelboin , H. V. , Penman , B. W. and Langenbach , R. 1991a . A metabolically competent cell line expressing five cDNAs encoding pro‐carcinogen‐activating enzymes: Application to mutagen testing . Chem. Res. Toxicol. , 4 : 566 – 572 .
   PubMed Web of Science ®Google Scholar
• Crespi , C. L. , Penman , B. W. , Gelboin , H. V. and Gonzalez , F. J. 1991b . A tobacco smoke‐derived nitrosamine 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butone (NNK) is activated by the polymorphic human cytochrome P4502D6 (CYP2D6) . Carcinogenesis , 12 : 1197 – 1201 .
   PubMed Web of Science ®Google Scholar
• Crespi , C. L. , Penman , B. W. , Steimel , P. T. , Gelboin , H. V. and Gonzalez , F. J. 1991c . The development of a human cell line stably expressing human CYP3A4: Role in the metabolic activation of aflatoxin B, and comparison to CYP1A2 and CYP2A3 . Carcinogenesis , 12 : 355 – 359 .
   PubMed Web of Science ®Google Scholar
• Daly , A. K. , Armstrong , M. , Monkman , S. C. , Idle , M. E. and Idle , J. R. 1991 . Genetic and metabolic criteria for the assignment of debrisoquine 4‐hydroxylation (cytochrome P4502D6) phenotypes . Pharmacogenetics , 1 : 26 – 32 .
   PubMedGoogle Scholar
• Diaz , D. , Fabre , I. , Daujat , M. , Saint Aubert , B. , Bories , P. , Michel , H. and Maurel , P. 1990 . Omeprazole is an aryl hydrocarbon‐like inducer of human hepatic cytochrome P450 . Gastroenterology , 99 : 737 – 747 .
   PubMed Web of Science ®Google Scholar
• Eichelbaum , M. and Gross , A. S. 1990 . The genetic polymorphism of debrisoquine/sparteine metabolism‐clinical aspects . Pharmacol. Ther. , 46 : 377 – 394 .
   PubMed Web of Science ®Google Scholar
• Gedhill , B. L. and Mauro , F. 1991 . New Horizons in Biological Dosimetry , New York : Wiley‐Liss .
   Google Scholar
• Gonzalez , F. J. 1992 . Human cytochromes P450. Problems and prospects . Trends Pharmacol. Sci. , 13 : 346 – 352 .
   PubMed Web of Science ®Google Scholar
• Gonzalez , F. J. and Meyer , U. A. 1991 . Molecular genetics of the debrisoquine/sparteine polymorphism . Clin. Pharm. Ther. , 50 : 233 – 238 .
   PubMed Web of Science ®Google Scholar
• Gonzalez , F. J. and Nebert , D. W. 1990 . Evolution of the P450 gene superfamily: Animal‐plant “warfare,” molecular drive and human genetic differences in drug oxidation . Trends Genet. , 6 : 182 – 187 .
   PubMed Web of Science ®Google Scholar
• Gonzalez , F. J. , Crespi , C. L. and Gelboin , H. V. 1991 . cDNA‐expressed human cytochrome P450: A new age of molecular toxicology and human risk assessment . Mutat. Res. , 247 : 113 – 127 .
   PubMed Web of Science ®Google Scholar
• Gu , L. , Gonzalez , F. J. , Kalow , W. and Tang , B. K. 1992 . Biotransformation of caffeine, paraxanthine, theobromine, and theophylline by cDNA expressed human CYP1A2 and CYP2E1 . Pbarmacogenetics , 2 : 73 – 77 .
   PubMedGoogle Scholar
• Guengerich , F. P. 1987 . Mammalian Cytochromes P450 , vols. 1 and 2 , Boca Raton, Fla. : CRC Press .
   Google Scholar
• Guengerich , F. P. and Shimada , T. 1991 . Oxidation of toxic and carcinogenic chemicals by human cytochrome P450 enzymes . Chem. Res. Toxicol. , 4 : 391 – 407 .
   PubMed Web of Science ®Google Scholar
• Hayashi , S. , Watanabe , J. , Nakachi , K. and Kawajiri , K. 1991 . Genetic linkage of lung cancer associated Msp I polymorphism with amino acid replacement in the heme binding region of the human cytochrome P4501A1 gene . J. Biochem. , 110 : 407 – 411 .
   PubMed Web of Science ®Google Scholar
• Hayashi , S. , Watanabe , J. and Kawajiri , K. 1992 . High susceptibility to lung cancer analyzed in terms of combined genotypes of P4501A1 and mu‐class glutathione S‐transferase genes . Jpn. J. Cancer Res. , 83 : 866 – 870 .
   PubMedGoogle Scholar
• Idle , J. R. , Armstrong , M. , Boddy , A. V. , Boustead , C. , Cholerton , S. , Cooper , J. , Daly , A. K. , Ellis , J. , Gregory , W. , Hadidi , H. , Hofer , C. , Holt , J. , Leathart , J. , McCracken , N. , Monkman , S. O. , Painter , J. E. , Taber , H. , Walker , D. and Yule , M. 1992 . The pharmacogenetics of chemical carcinogenesis . Pharmacogenetics , 2 : 246 – 258 .
   PubMedGoogle Scholar
• Imaoka , S. , Ogawa , H. , Kimura , S. and Gonzales , F. J. 1993 . Complete cDNA sequence and cDNA‐directed expression of CYP4A11, a fatty acid co‐hydroxylase expressed in human kidney . DNA Cell Biol. , in press
   PubMedGoogle Scholar
• Kalow , W. 1962 . Pharmacogenetics: Heredity and the Response to Drugs , Philadelphia : W. B. Saunders .
   Google Scholar
• Kalow , W. 1991 . Interethnic variation of drug metabolism . Trends Pharmacol. Sci. , 12 : 102 – 107 .
   PubMed Web of Science ®Google Scholar
• Kalow , W. and Tang , B. K. 1991 . Use of caffeine metabolite ratios or explore CYP1A2 and xanthine oxidase . Clin. Pharm. Ther. , 50 : 508 – 519 .
   PubMed Web of Science ®Google Scholar
• Lambert , G. H. , Schoeller , D. A. , Humphrey , H. E. and Kotake , A. W. 1990 . The caffeine breath test and caffeine urinary metabalite ratios in the Michigan cohort exposed to polybrominated biphenyls: A preliminary study . Environ. Health Perspect. , 89 : 175 – 181 .
   PubMed Web of Science ®Google Scholar
• McLemore , T. , Adelberg , S. , Liu , M. C. , McMahon , N. A. , Yu , S. J. , Hubbard , W. C. , Czerwinski , M. , Coudert , B. P. , Moscow , J. A. , Stinson , S. , Storeng , R. , Lubet , R. A. , Eggleston , J. C. , Boyd , M. R. and Hines , R. N. 1990 . Cytochrome P4501A1 gene expression in living cancer patients: Evidence for cigarette smoke‐induced expression in normal lung and altered gene regulation in primary pulmonary carcinomas . JNCI , 82 : 1333 – 1339 .
   PubMed Web of Science ®Google Scholar
• Miao , V. P. , Covert , S. F. and VanEtten , H. D. 1991 . A fungal gene for antibiotic resistance on a dispensable (B) chromosone . Science , 254 : 1773 – 1776 .
   PubMed Web of Science ®Google Scholar
• Nakachi , K. , Imai , K. , Hayashi , S. , Watanabe , J. and Kawajiri , K. 1991 . Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose . Cancer Res. , 51 : 5177 – 5180 .
   PubMed Web of Science ®Google Scholar
• Nebert , D. W. 1986 . The genetic regulation of drug‐metabolying enzymes . Drug Metab. Dispos. , 16 : 1 – 8 .
   Web of Science ®Google Scholar
• Nelson , D. R. , Kamataki , T. , Waxman , D. J. , Guengerich , F. P. , Estabrook , R. W. , Feyereisen , R. , Gonzalez , F. J. , Coon , M. J. , Gunsalus , I. C. , Gotoh , O. , Okuda , K. and Nebert , D. W. 1993 . The P450 superfamily: Update on new sequences, gene mapping, accession numbers, early trivial names of enzymes and nomenclature . DNA Cell Biol. , 14 : 1 – 60 .
   Google Scholar
• Peter , R. , Bocker , R. G. , Beaune , P. H. , Iwasaki , M. , Guengerich , F. P. and Yang , C. S. 1990 . Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P450 IIE1 . Chem. Res. Toxicol. , 3 : 566 – 573 .
   PubMed Web of Science ®Google Scholar
• Rautio , A. , Kraul , H. , Kojo , A. , Salmela , E. and Pelkonen , O. 1992 . Interindividual variability of coumarin 7‐hydroxylation in healthy volunteers . Pharmacogenetics , 2 : 227 – 233 .
   PubMedGoogle Scholar
• Smith , C. A. D. , Gough , A. C. , Leigh , P. N. , Summers , B. S. , Harding , A. E. , Maranganore , D. M. , Sturman , S. G. , Schapira , A. H. V. , Williams , A. C. , Spurr , N. K. and Wolf , C. R. 1992 . Debrisoquine polymorphism and susceptibility to Parkinson's disease . Lancet , 339 : 1375 – 1377 .
   PubMed Web of Science ®Google Scholar
• Sugden , B. , March , K. and Yates , J. 1985 . A vector that replicates as a plasmid and can be efficiently selected in B‐lymphoblast transformed by Epstein‐Barr virus . Mol. Cell. Biol. , 5 : 410 – 418 .
   PubMedGoogle Scholar
• Tefre , T. , Ryberg , D. , Haugen , A. , Nebert , D. W. , Skaug , V. , Brogger , A. and Borresen , A. 1991 . Human CYP1A1 (cytochrome P,450) gene: Lack of association between the Msp I restriction fragmerit length polymorphism and incidence of lung cancer in a Norwegian population . Pharmacogenetics , 1 : 20 – 25 .
   PubMedGoogle Scholar
• Watkins , P. B. , Wrighton , S. A. , Schuetz , E. G. , Molowa , D. T. and Guzelian , P. S. 1987 . Identification of glucocorticoid‐inducible cytochromes P450 in the intestinal mucosa of rats and man . J. Clin. Invest. , 80 : 1024 – 103622 .
   Google Scholar
• Watkins , P. B. , Turgeon , D. K. , Saenger , P. and Lown , K. S. 1992 . Comparison of urinary 6‐beta‐cortisol and the erythromycin breath test as measures of hepatic P450IIIA (CYP3A) activity . Clin. Pharm. Ther. , 52 : 265 – 73 .
   PubMed Web of Science ®Google Scholar